arrow
Back
J

Josep Tabernero

Vall d'Hebron Barcelona Hospital Campus

146H-index
2.7KPaper Count
12.7WCitation Count
Published Papers 689
Publication Date
A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3
err2026-05-31
err0
errOAAI
errS. Kopetz; J. Tabernero; S. Lonardi; L. Shen; H.S. Wasan; T. Yoshino; E. Van Cutsem; T.W. Kim; C. Eng; F. Ciardiello; J. Desai; T.S. Maughan; R. Yaeger; T. Usari; Xiaoxi Zhang; E. Beyzarov; A. Mori; E. Whalley; Xiaosong Zhang; E. Elez
errShare
errSave
Quality and safety of research biopsies in oncology clinical trials.
err2026-05-25
err0
errOAAI
errPaolo Nuciforo; Fiorella Ruiz-Pace; José Jimenez; Raquel Comas; Roberta Fasani; Cristina Viaplana; Cesar Sevillano; Paola Martinez; Xavier Serres-Créixams; Nuria Roson; Cristina Saura; Elena Elez; Ana Oaknin; Irene Braña Garcia; Eva Muñoz-Couselo; Teresa Macarulla Mercade; Joan Carles; Josep Tabernero; Enriqueta Felip; Elena Garralda
errShare
errSave
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of cergutuzumab amunaleukin: a phase I study in patients with advanced and/or metastatic solid tumors
err2026-05-13
err0
errOAAI
errU. Lassen; E.M.J. van Brummelen; I. Melero; E. Angevin; H. Joensuu; N.H. Segal; M. Mau-Sørensen; N. Steeghs; M.E. Rodríguez-Ruiz; K. Homicsko; J. Tabernero; M. Cañamero; D. Dejardin; C. Habigt; E. Rossmann; E. Guarin; G. Babitzki; H.E.S. Baumann; A.P. Silva; C. Adessi
errShare
errSave
Epigenetic fingerprints link early-onset colon and rectal cancer to pesticide exposure
err2026-04-21
err0
errOAAI
errSilvana C. E. Maas; Iosune Baraibar; Lea Lemler; Maria Butjosa-Espín; Odei Blanco Irazuegui; Josep Tabernero; Elena Elez; Jose A. Seoane
errShare
errSave
Genomic Landscape, Targeted Therapies, and Mechanisms of Resistance in Molecularly Selected Metastatic Colorectal Cancer Patients
errGenes
IF2.8
err2026-04-15
err0
errOAAI
errPatricia Garcia Pastor; Nadia Saoudi González; Francesc Salva; Javier Ros; Iosune Baraibar; Marta Rodríguez Castells; Clara Salva de Torres; Ariadna García; Adriana Alcaraz; Caterina Vaghi; Josep Tabernero; Elena Elez
errShare
errSave
New prognostic and predictive scoring systems for colorectal cancer liver metastases
err2026-04-09
err0
errOAAI
errF. Salvà; S. Pérez Fernandez; C. Dopazo; M. Salcedo; N. Saoudi; M. Rodriguez; I. Baraibar; J. Ros; C. Salva de Torres; C. Vaghi; Z. Calixto; C. Gómez-Gavara; M. Caralt; G. Sapisochin; J. Tabernero; E. Elez
errShare
errSave
Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities
err2025-12-15
err0
errOAAI
errUlrik Ringborg; Joachim von Braun; Julio Celis; Anton Berns; Michael Baumann; Tit Albreht; Nancy Abou-Zeid; Vanderlei Bagnato; Christian Brandts; Chien-Jen Chen; Massimiliano di Pietro; Manjit Dosanjh; Thomas Dubois; Alexander Eggermont; Angelika Eggert; Ingemar Ernberg; Sara Faithfull; Johannes Förner; Stefan Fröhling; Manuel Heitor; Leroy Hood; Wei Jiang; Bengt Jönsson; Ravi Kannan; Maria Leptin; Su Li; Peter Lindgren; Douglas Lowy; Jun Ma; Alex Markham; Péter Nagy; Simon Oberst; M. Iqbal Parker; Danielle Rodin; Kevin Ryan; Joachim Schüz; Richard Sullivan; Josep Tabernero; Peter Turkson; Oliver Várhelyi; Harold Varmus; Chijie Wang; Elisabete Weiderpass; Nils Wilking
errShare
errSave
Tislelizumab + Chemotherapy in Gastric Cancer: Long-Term RATIONALE-305 Randomized Trial Follow-up
err2025-11-18
err0
errOAAI
errMarcia Cruz-Correa; Do-Youn Oh; Ken Kato; Josep Tabernero; Yuxian Bai; Jianhua Shi; Keun-Wook Lee; Hidekazu Hirano; David Spigel; Lucjan Wyrwicz; Roberto Pazo Cid; Antonio Cubillo Gracián; Yaling Xu; Tao Sheng; Silu Yang; Rui-Hua Xu; Markus Moehler
errShare
errSave
Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors
err2025-11-06
err0
errOAAI
errR. Dienstmann; A. Vivancos; P. Nuciforo; S. Aguilar; F. Ruiz-Pace; C. Viaplana; J. Gonzalez; B. Fite; A. Pedrola; E. Elez; C. Saura; E. Felip; T. Macarulla; J. Capdevila; L. Fariñas-Madrid; J. Carles; J. Mateo; E. Muñoz-Cosuelo; J. Balmaña; I. Braña; E. Garralda; J. Tabernero
errShare
errSave
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
err2025-10-20
err0
PREAI
errJ Randolph Hecht; Young Suk Park; Josep Tabernero; Myung-Ah Lee; Soohyeon Lee; Anna C Virgili; Marc Van den Eynde; Elisa Fontana; Marwan Fakih; Gholamreza Asghari; Jane So; Alexander Stein; Olivier Dubreuil; Lubomir Bodnar; Cixin Steven He; Guan Wang; Robina Smith; Cathy Eng; Anwaar Saeed
errShare
errSave
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial
err2025-09-30
err0
errOAAI
errE. Seguí; F. Brasó-Maristany; T. Pascual; E. Sanfeliu; I. Victoria; C. Saura; C. Hierro; A. López-González; Y. Izarzugaza; E. Ciruelos; J. Gavilá; F. Racca; J.M. Cejalvo; K. Amillano; L. Paz-Ares; M. Juan; E. Felip; E. Garralda; B. González; A. Arance; J. Martín-Liberal; B. Conte; B. Walbaum; A. Indacochea; O. Castillo; P. Blasco; F. Pardo; Á. Aguirre; V. Sirenko; X. González; P. Galván; A. Vivancos; J.M. Ferrero-Cafiero; A. Mulero-Sánchez; F. Salvador; G. Villacampa; R. Mesía; A. Cervantes; A. Prat; J. Tabernero
errShare
errSave
Implementation of the precision oncology program in catalonia’s public health system: results, lessons learned, and future prospects
err2025-09-03
err0
errOAAI
errPilar Mur; Anna Pozuelo; Josep Tabernero; Joan Albanell; Beatriz Bellosillo; Francesc Bosch; Javier Briones; Joan Brunet; Dolors Colomer; Montserrat Domènech; Joan Manel Fontanet; Xavier Matias-Guiu; Ramon Salazar; Rosa Maria Vivanco-Hidalgo; Meritxell Mollà; Lucas Moreno; Aleix Prat; Josep Maria Ribera; Ramón Clèries; Alex Guarga; Josep A. Espinàs; Josep Maria Borras
errShare
errSave
Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases―the PURPLE trial
err2025-09-01
err0
errOAAI
errKasper, S.; Elez, E.; Neumann, U.; Lang, S.; Trampe, A. -K.; Salva, F.; Dopazo, C.; Virchow, I.; Hartmann, S.; Herrmann, K.; Tabernero, J.; Westendorf, A.; Schuler, M.; Schramm, A.
errShare
errSave
Differentiating low tumor burden from oligometastatic disease in colorectal cancer: a call for individualized therapeutic approaches
err2025-08-12
err0
errOAAI
errM.C. de Grandis; I. Baraibar; O. Prior; M. Balaguer-Montero; F. Salvà; J. Ros; M. Rodríguez-Castells; J. Tabernero; S. Lonardi; R. Perez-Lopez; E. Élez
errShare
errSave
Petosemtamab, a Bispecific Antibody Targeting Epidermal Growth Factor Receptor (EGFR) and Leucine-Rich G Repeat-Containing Protein-Coupled Receptor (LGR5) Designed for Broad Clinical Applications
errCANCERS
IF4.4
err2025-05-14
err0
errOAAI
errLundberg, Ante S.; Geuijen, Cecile A. W.; Hill, Sally; Lammerts van Bueren, Jeroen J.; Fumagalli, Arianna; de Kruif, John; Silverman, Peter B.; Tabernero, Josep
errShare
errSave
A plain language summary of the molecular changes in the tumors of people with BRAF V600E-mutant colorectal cancer in the BEACON study
err2025-05-09
err0
errOAAI
errKopetz, Scott; Murphy, Danielle A.; Pu, Jie; Ciardiello, Fortunato; Desai, Jayesh; Van Cutsem, Eric; Wasan, Harpreet Singh; Yoshino, Takayuki; Saffari, Hedieh; Zhang, Xiaosong; Hamilton, Phineas; Xie, Tao; Yaeger, Rona; Tabernero, Josep
errShare
errSave
A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC)
err2025-04-10
err0
errOAAI
errAroldi, Francesca; Elez, Elena; Andre, Thierry; Perkins, Geraldine; Prenen, Hans; Popovici, Vlad; Gallagher, Peter; Houlden, Jennifer; Collins, Linda; Roberts, Corran; Rolfo, Christian; Di Nicolantonio, Federica; Grayson, Margaret; Boyd, Ruth; Bettens, Karolien; Delfavero, Jurgen; Coyle, Victoria; Lawler, Mark; Khawaja, Hajrah; Laurent-Puig, Pierre; Salto-Tellez, Manuel; Maughan, Tim S.; Tabernero, Josep; Adams, Richard; Jones, Robert; Hennessy, Bryan T.; Bardelli, Alberto; Peeters, Marc; Middleton, Mark R.; Wilson, Richard H.; Van Schaeybroeck, Sandra
errShare
errSave
Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2
err2025-03-01
err0
errOAAI
errStintzing, S.; Tabernero, J.; Satoh, T.; Dasari, A.; Lonardi, S.; Eng, C.; Garcia-Carbonero, R.; Elez, E.; Yoshino, T.; Sobrero, A. F.; Yao, J. C.; Kasper, S.; Arnold, D.; Basic, E.; Granold, M.; Petschulies, M.; Wu, L.; Chung, Y. -C; Chen, L.; Yang, Z.; Van Cutsem, E.
errShare
errSave
First-Line Tislelizumab Plus Chemotherapy for Advanced Gastric Cancer with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-305
err2025-03-01
err0
errOAAI
errMoehler, Markus; Oh, Do-Youn; Kato, Ken; Arkenau, Tobias; Tabernero, Josep; Lee, Keun-Wook; Rha, Sun Young; Hirano, Hidekazu; Spigel, David; Yamaguchi, Kensei; Wyrwicz, Lucjan; Disel, Umut; Pazo-Cid, Roberto A.; Fornaro, Lorenzo; Xu, Yaling; Sheng, Tao; Yang, Silu; Kadva, Alysha; Cruz-Correa, Marcia; Xu, Rui-Hua
errShare
errSave